SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
RNAi
An SI Board Since May 2003
Posts SubjectMarks Bans
671 52 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
546From NATURE|Vol 448|23 August 2007 NEWS FEATURE (Very interesting, I have the fuidos-8/23/2007
545Quark Pharmaceuticals Extends Research Agreement with State University of New Yoidos-8/20/2007
544RNAi delivery-solved partially: Nature Reviews Drug Discovery 6, 601 (August 20idos-8/6/2007
543RNAi delivery-solved partially: Nature Reviews Drug Discovery 6, 601 (August 20idos-8/6/2007
542Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic Ridos-8/2/2007
541Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in ntnsaf-8/2/2007
540ALNY, MDT ink RNAi collaboration for Huntington’s disease: biz.yahoo.comDewDiligence_on_SI-7/30/2007
539Article on thestreet.com (July 12th) on RNAi. Check it out.jh2006-7/12/2007
538First RNAi drug (such as it is) makes it to phase-3: investorshub.comDewDiligence_on_SI-7/11/2007
537Ouch. Missed opportunities are at least as painful to me as real losses. EOMA.J. Mullen-7/10/2007
536I wince every time I look at them. I had a decent position (in what was then Snigel bates-7/10/2007
535Thanks for that on SLN Nigel. I'm surprised the stock has dropped since. $A.J. Mullen-7/10/2007
534Silence Therapeutics Signs siRNA Research & Development Collaboration With Anigel bates-7/6/2007
533TransKingdom RNAi? investorshub.comDewDiligence_on_SI-6/18/2007
532You’re a little slow on the uptake: investorshub.com :-) Good call, though.DewDiligence_on_SI-4/4/2007
531Soon we'll have Acuity to kick around as a public company. It and Froptix (tuck-4/4/2007
530Somewhat OT... Theoretical RNA research, not RNAi specifically. ++++++++++++++Ian@SI-3/22/2007
529Hey Tuck, This sounds pretty intriguing as a delivery mechanism (old article, thThomas-3/21/2007
528Who thinks this is/isn’t a consequential patent? T.i.a.DewDiligence_on_SI-3/1/2007
527Alnylam and Isis Announce Allowance of First U.S. Patent Covering Human microRNAnigel bates-3/1/2007
526Public release date: 14-Feb-2007 Contact: Julie A. Penne jpenne@mandanderson.orIan@SI-2/14/2007
525SR Pharma Plc Announces Start of Phase I Trial With Novel RNAi Therapeutic RTP-8nigel bates-2/5/2007
524Today's News... Inex (IEX.t) provides liposomal licence to Alnylam 2007-01RadMan55-1/10/2007
523<i>CYTR, a minnow that had been considered an also-ran to ALNY and RNAI atDewDiligence_on_SI-1/9/2007
522CYTR, a minnow that had been considered an also-ran to ALNY and RNAI at best, antuck-1/9/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News